Technical Analysis for JANX - Janux Therapeutics, Inc.

Grade Last Price % Change Price Change
D 22.86 0.44% 0.10
JANX closed up 0.44 percent on Monday, October 25, 2021, on 24 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical JANX trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
20 DMA Support Bullish 0.44%
Upper Bollinger Band Touch Strength 0.44%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -8.63%
Above Upper BB Strength -8.63%
Up 3 Days in a Row Strength -8.63%
Up 4 Days in a Row Strength -8.63%
Upper Bollinger Band Touch Strength -8.63%
Crossed Above 20 DMA Bullish 2.33%
Up 3 Days in a Row Strength 2.33%
Older End-of-Day Signals for JANX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% about 19 hours ago
60 Minute Opening Range Breakout about 19 hours ago
Up 1% about 19 hours ago
20 DMA Support about 20 hours ago
10 DMA Support about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. It is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. The company was incorporated in 2017 and is headquartered in La Jolla, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Immunology Immune System Tumor Platform Technology Chimeric Antigen Receptor T Cell T Cell Clusters Of Differentiation

Is JANX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.99
52 Week Low 16.32
Average Volume 166,324
200-Day Moving Average 0.00
50-Day Moving Average 26.08
20-Day Moving Average 21.95
10-Day Moving Average 22.03
Average True Range 2.35
ADX 14.81
+DI 19.72
-DI 16.81
Chandelier Exit (Long, 3 ATRs) 18.14
Chandelier Exit (Short, 3 ATRs) 25.42
Upper Bollinger Bands 24.37
Lower Bollinger Band 19.52
Percent B (%b) 0.69
BandWidth 22.09
MACD Line -0.85
MACD Signal Line -1.37
MACD Histogram 0.5185
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.89
Resistance 3 (R3) 25.72 24.55 25.39
Resistance 2 (R2) 24.55 23.78 24.63 25.22
Resistance 1 (R1) 23.70 23.30 24.13 23.87 25.05
Pivot Point 22.53 22.53 22.74 22.61 22.53
Support 1 (S1) 21.68 21.76 22.11 21.85 20.67
Support 2 (S2) 20.51 21.28 20.59 20.50
Support 3 (S3) 19.66 20.51 20.34
Support 4 (S4) 19.83